Comment on: Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study.

Rheumatology (Oxford)

Primary Care Department, Azienda Sanitaria Provinciale Catanzaro, Casa della Salute 'Chiaravalle Centrale', Catanzaro, Chiaravalle, Italy.

Published: April 2022

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keab849DOI Listing

Publication Analysis

Top Keywords

comment risk
4
risk giant
4
giant cell
4
cell arteritis
4
arteritis polymyalgia
4
polymyalgia rheumatica
4
rheumatica covid-19
4
covid-19 vaccination
4
vaccination global
4
global pharmacovigilance
4

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!